LIAISON XL MUREX HIV Ab/Ag HT - HIV1/HIV2 antigen/antibody IVD, kit, chemiluminescent immunoassay

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Available from:

DiaSorin Australia Pty Ltd

Class:

Class 4

Manufactured by:

DiaSorin Italia SpA Via Crescentino snc, Saluggia VC, 13040 Italy

Therapeutic area:

48446 - HIV1/HIV2 antigen/antibody IVD, kit, chemiluminescent immunoassay

Therapeutic indications:

The LIAISON? XL murex HIV Ab / Ag HT assay uses chemiluminescence immunoassay (CLIA) technology for the combined qualitative determination of p24 antigen of human immunodeficiency virus type 1 (HIV-1) and specific antibodies to both human immunodeficiency virus type 1 (group M and group O) and/or human immunodeficiency virus type 2 (HIV-2) in human serum or plasma samples. IVDs that are intended to be used in testing to provide information about infection with or exposure to Human immunodeficiency viruses (HIV)

Authorization status:

A

Authorization date:

2016-08-31